maxsmith059

11.01.2021

The global orthobiologics market was valued at $4,870 million in 2017 and is projected to reach $6,870 million by 2025, registering a CAGR of 4.3% from 2018 to 2025. Orthobiologics are also called regenerative cellular therapies. Products related to orthobiologics contain growth factors or sometimes secrete growth factors to facilitate tissue healing, improve pain, and help restore normal functioning. There are various types of orthobiologics present in the market, which rely on different mechanisms of actions. An autologous is derived from a patient's own body, which under right conditions divides to form precursor cells. Orthobiologics find their application for the treatment of conditions such as fracture recovery, spinal fusion, and others.

male